NCT00002017View on ClinicalTrials.gov

Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Interleukin-2, Polyethylene Glycolated

Trial Locations (1)

10021

Rockefeller Univ, New York

All Listed Sponsors

lead

Rockefeller University

OTHER

NCT00002017 - Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2 | Biotech Hunter | Biotech Hunter